NCT03546153

Brief Summary

By doing this study, researchers hope to learn effects of aerobic exercise on over activated nervous system in people with chronic low back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 6, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

September 27, 2019

Status Verified

September 1, 2019

Enrollment Period

1.3 years

First QC Date

May 22, 2018

Last Update Submit

September 26, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pain sensitivity (Pressure pain threshold)

    Sensitivity will be measured using a pressure algometer.

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • 2011 FM survey

    Sensitivity will be measured using the 2011 Fibromyalgia (FM) Survey Criteria. The survey includes widespread pain index and symptom severity scale. The total score is 31 and scores more than 13 is considered fibromyalgia positive, suggesting presence of central sensitization.

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • Opioid consumption

    Use of opioids (dose, frequency, and duration) will be obtained by interviewing the subjects

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • Oswestry Disability Index

    This questionnaire consists of questions related to daily functions and degrees to which back pain interferes with these functions. Each items is measured on a 6-point scale with a total possible score of 50. Higher numbers indicate greater disability.

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

Secondary Outcomes (7)

  • Pain Sensitivity (CPM test)

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • Fear Avoidance Belief Questionnaire

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • Pain Catastrophizing Scale

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • Beck Depression Inventory

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • Beck Anxiety Inventory

    Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  • +2 more secondary outcomes

Study Arms (1)

Aerobic exercise program

EXPERIMENTAL

Participants will complete 12 week exercise program.

Behavioral: Aerobic exercise program

Interventions

Exercise program consists of training for 60 minutes, three times per week for 12 weeks. Participants will use a treadmill, Nu stepper/bike or elliptical to exercise.

Aerobic exercise program

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Lower back pain (LBP) for more than 3 months
  • A minimal pain level of 3 on the 0-10 pain numerical rating scale (NRS) in the last 7 days
  • Can read and understand English.

You may not qualify if:

  • Nerve root compression that resulted in numbness or decrease in sensation in the areas for the pain sensitivity tests as reported by the subject
  • cervical or thoracic pain as a main complaint
  • spinal pathologies such as fracture, tumor, infection, and severe inflammation
  • severe spinal deformity
  • severe cardiovascular and neurological diseases
  • cancer
  • history of spinal surgery
  • currently seeking active treatments for LBP other than medications
  • resting blood pressure more than 160/90 mmHg 49
  • currently taking blood thinning medications
  • uncontrolled diabetes
  • cannot have blood pressure taken
  • participated in a similar trial in the past

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Location

Study Officials

  • Neena Sharma, PT, PhD, CMPT

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2018

First Posted

June 6, 2018

Study Start

June 1, 2018

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

September 27, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations